国际肿瘤学杂志 ›› 2014, Vol. 41 ›› Issue (7): 541-545.doi: 10.3760/cma.j.issn.1673422X.2014.07.018

• 论著 • 上一篇    下一篇

血清胃蛋白酶原对胃癌癌前病变的诊断价值研究

张俊旺,甄俊红,师水生,毓珊,王守桃,齐莹   

  1. 030001太原,山西医科大学第二医院消化内科(张俊旺、师水生、毓珊、王守桃、齐莹),检验科(甄俊红)
  • 出版日期:2014-08-04 发布日期:2014-08-04
  • 通讯作者: 张俊旺,Email:junwangzhang@126.com E-mail:junwangzhang@126.com

The study on the diagnostic value of serum pepsinogens to gastric precancerous lesions

 ZHANG  Jun-Wang, ZHEN  Jun-Hong, SHI  Shui-Sheng, YU  Shan, WANG  Shou-Tao, QI  Ying   

  1. *Digestive System Department and Clinical Laboratory Centre of the Shanxi Medical University 2nd Hospital. Taiyuan 030001, China
  • Online:2014-08-04 Published:2014-08-04
  • Contact: Zhang Junwang E-mail:junwangzhang@126.com

摘要: 目的通过检测血清胃蛋白酶原在胃黏膜不同病理状态下的表达水平,探讨其作为临床筛查胃癌标志物的可能性及定量范围。方法用时间分辨荧光免疫分析(TRFIA)法检测63例胃黏膜非典型增生、64例慢性萎缩性胃炎、67例胃癌患者和20例健康志愿者血清胃蛋白酶原(PG)Ⅰ、Ⅱ的含量,计算PGⅠ/PGⅡ比值(PGR),并对3类病变进行等级分组,比较PG水平在组间和组内差异。结果①与健康对照组(152.00 μg/L)比较,萎缩性胃炎、非典型增生和胃癌患者PGⅠ水平中位数值分别为124.01、91.23和71.23 μg/L,差异有统计学意义(Z=-2.52, P=0.017 0;Z=-3.42,P=0.001 4;Z=-3.57, P=0.000 9)。PGR水平M值分别为7.61、5.21和4.32,低于健康组(15.38),差异有统计学意义(Z=-2.98,P=0.002 9;Z=-3.17,P=0.000 2;Z=-2.89,P=0.000 1);PGⅡ与健康组比较差异无统计学意义(P>0.05)。②非典型增生和胃癌组血清PGⅠ水平与萎缩组比较差异有统计学意义(Z=-2.42,P=0.002 4;Z=-3.62,P=0.000 9);PGⅡ和PGR水平差异无统计学意义(P>0.05)。③血清PGⅠ水平在萎缩性胃炎和胃癌组3个级别小组内比较差异无统计学意义(χ2=2.86,P=0.414 3;χ2=1.67,P=0.136 8);而PGⅠ在非典型增生组,轻中度呈下降趋势,重度升高,差异有统计学意义(χ2=0.83,P=0.043 0),PGⅡ水平和PGR差异无统计学意义(P>0.05)。④以正常组和胃黏膜非典型增生组的血清PGⅠ和PGR所作的受试者工作特征(ROC)曲线下的面积分别为0.782和0.831;以血清PGI≤72.12 μg/L和PGR≤4.32作为临界值筛查胃黏膜非典型增生的敏感性和特异性分别为89.48%和76.31%。结论①随胃黏膜病变严重程度增加,PGⅠ水平和PGR呈下降趋势,PG有可能作为胃黏膜恶性变的筛查标记物。②血清PG水平与胃黏膜病变密切相关,以血清PGI≤72.12 μg/L联合PGR≤4.32作为临界值筛查胃黏膜非典型增生在本地区可能具有较好的敏感性和特异性。

关键词: 胃蛋白酶原类, 萎缩, 癌前状态, 荧光免疫测定

Abstract: ObjectiveTo investigate the possibility and quantitative range of pepsinogen(PG) used as the screening marker of gastric cancer by detecting serum pepsinogen level in different gastric mucous pathologic status. MethodThe level of serum pepsinogenⅠ(PGⅠ) and pepsinogenⅡ(PGⅡ) by time resolved fluoroimmunoassay(TRFIA) in 64 chronic atrophic gastritis patients,63 gastric mucous atypical hyperplasia patients, 67 gastric cancer patients and 20 healthy volunteers were defeeted , and the ratio of PGR(PGⅠ/ PGⅡ) was calculated. Then the three kinds of diseases were graded. The data was analyzed between groups and subgroups. Result①Compared with normal control group, the median PGⅠvalues were 124.01,91.23 and 71.23 respectively, which were all lower than that of healthy group (152.00). There were significant differences(Z=-2.52,P=0.017 0;Z=-3.42,P=0.001 4;Z=-3.57,P=0.000 9).The median PGR values were 7.61,5.21 and 4.32 respectively, which were also lower than that of healthy group, the differences were significant(Z=-2.98,P=0.002 9;Z=-3.17,P=0.000 2;Z=-2.89, P=0.000 1). The PGⅡlevel of these diseases were not significantly different with control group. ②The serum PGⅠlevel of gastric mucous atypical hyperplasia and gastric cancer were reduced significantly in contrast with atrophic gastritis (Z=-3.42,P =0.001 4;Z=-3.62,P=0.000 9); the levels of PGⅡ and PGR were varied without significance(P>0.05); ③The levels of PGⅠamong atrophy gastritis and gastric cancer subgroup have no significant difference(χ2=2.86,P=0.414 3;χ2=1.67,P=0.136 8).But the level of PGⅠwas significantly different in gastric atypical hyperplasia(χ2=0.83,P=0.043 0).It decreased in light and medium grade dysplasia and went up in severe grade dysplasia. The levels of PGⅡ and PGR were varied without significance(P>0.05). ④The areas under the ROC curves performed by the PGⅠ and PGR from normal control group and atypical hyperplasia group were 0.782 and 0.831 respectively; The sensitivity and specificity of PGⅠ≤72.12 μg/L and PGR≤4.32 for gastric dysplasia were 89.48% and 76.31% respectively. Conclusion①The level of PGⅠand PGR were decreased along with the seriousness of gastric pathological changes and probably regarded as the screening markers of gastric mucous malignant transformation.②Serum pepsinogen level is closely correlated with gastric precancerous lesion, PGI≤72.12 μg/L and PGR≤4.32 has better specificity and sensitivity for gastric atypical hyperplasia in this area.

Key words: Pepsinogens, Atrophic, Precancerous conditions, Fluoroimmunoassay